Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2010-03-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To facilitate safe use of ropivacaine as an analgesic, information on the concentrations levels after autologous blood transfusion following local infiltration analgesia is very crucial. However, very limited data are available. To verify the safety of autologous blood transfusion, ropivacaine concentrations were studied in 52 patients undergoing either total knee arthroplasty or total hip arthroplasty.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty
NCT04691362
Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA)
NCT00980616
An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study
NCT02385383
Reinfusion Drains vs Tranexamic Acid in Total Joint Arthroplasty
NCT01636414
Topical Tranexamic Acid and Acute Blood Loss in Total Knee Arthroplasty
NCT01370460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Total knee arthroplasty
25 consecutive patients diagnosed for total knee arthroplasty.
Autologous blood transfusion with ropivacaine
Local infiltration analgesia with ropivacaine 3 mg/kg, max 200 mg
Total hip arthroplasty
27 patients diagnosed for total hip arthroplasty.
Autologous blood transfusion with ropivacaine
Local infiltration analgesia with ropivacaine 3 mg/kg, max 200 mg.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autologous blood transfusion with ropivacaine
Local infiltration analgesia with ropivacaine 3 mg/kg, max 200 mg
Autologous blood transfusion with ropivacaine
Local infiltration analgesia with ropivacaine 3 mg/kg, max 200 mg.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis for knee arthroplasty
Exclusion Criteria
* Lack of informed consent
* Inability to read/understand Danish
* Bilateral diagnosis
* Cancer diagnosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northern Orthopaedic Division, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ole Simonsen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Northern Orthopaedic Department, Aalborg University Hospital, Denmark
Sten Rasmussen, M.D.
Role: STUDY_CHAIR
Northern Orthopaedic Division, Aalborg University Hospital, Denmark
Bjarne B. Dencker, M.D.
Role: STUDY_CHAIR
Department of Anaesthesiology, Aalborg University Hospital, Denmark
Torben Breindahl, M.D.
Role: STUDY_CHAIR
Department of Clinical Biochemistry, Vendsyssel Hospital, Aarhus University, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vendsyssel Hospital, Frederikshavn, Aalborg Hospital, Aarhus University
Aalborg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20090061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.